We are live on ! Find out more
Cetera Investment Advisers

Cetera Investment Advisers Portfolio holdings

AUM $94B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+20.14%
3 Year Est. Return
+58.25%
5 Year Est. Return
+64.18%
10 Year Est. Return
+205.3%
AUM
$94B
AUM Growth
+$2.51B
Cap. Flow
+$4.21B
Cap. Flow %
4.48%
Top 10 Hldgs %
16.07%
Holding
5,012
New
327
Increased
2,706
Reduced
1,648
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 9.01%
2 Financials 3.8%
3 Industrials 3.06%
4 Consumer Discretionary 2.84%
5 Healthcare 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JFU
4576
9F Inc
JFU
$23.9M
$40.3K ﹤0.01%
+10,325
New +$51.7K
OXSQ icon
4577
Oxford Square Capital
OXSQ
$163M
$40.3K ﹤0.01%
22,748
-1,294
-5% -$2.34K
NNOX icon
4578
Nano X Imaging
NNOX
$68.2M
$40K ﹤0.01%
17,616
+1,381
+9% +$3.63K
GEMI
4579
Gemini Space Station
GEMI
$493M
$39.9K ﹤0.01%
+9,025
New +$71K
PYXS icon
4580
Pyxis Oncology
PYXS
$168M
$39.8K ﹤0.01%
27,260
GALT icon
4581
Galectin Therapeutics
GALT
$196M
$39.7K ﹤0.01%
14,220
BTQ
4582
BTQ Technologies Corp
BTQ
$500M
$39.6K ﹤0.01%
14,841
+3,179
+27% +$11.2K
ABCL icon
4583
AbCellera Biologics
ABCL
$1.74B
$39.4K ﹤0.01%
11,298
+70
+0.6% +$252
ALIT icon
4584
Alight
ALIT
$447M
$39.3K ﹤0.01%
3,372
-500
-13% -$11.9K
EDIT icon
4585
Editas Medicine
EDIT
$396M
$38.7K ﹤0.01%
15,674
-414
-3% -$876
TLT icon
4586
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$38.6K ﹤0.01%
+16,700
New +$1.47M
USEA icon
4587
United Maritime
USEA
$25.1M
$38.5K ﹤0.01%
19,041
VLO icon
4588
PUT
Valero Energy
VLO
$92.9B
$38.4K ﹤0.01%
+4,200
New +$866K
OVID icon
4589
Ovid Therapeutics
OVID
$414M
$37.7K ﹤0.01%
17,000
-1
-0% -$2
HIVE
4590
HIVE Digital Technologies
HIVE
$774M
$37.2K ﹤0.01%
19,555
+659
+3% +$1.63K
AISP
4591
Airship AI Holdings
AISP
$60.3M
$37.1K ﹤0.01%
16,413
+2,189
+15% +$6.2K
ZENA
4592
ZenaTech Inc
ZENA
$114M
$35.7K ﹤0.01%
+15,585
New +$47.2K
REAX icon
4593
Real Brokerage
REAX
$349M
$35K ﹤0.01%
14,016
-10,502
-43% -$31.8K
HUMA icon
4594
Humacyte
HUMA
$176M
$34.8K ﹤0.01%
57,307
-10,825
-16% -$11.3K
MX icon
4595
Magnachip Semiconductor
MX
$119M
$34.6K ﹤0.01%
12,368
UNH icon
4596
CALL
UnitedHealth
UNH
$376B
$34.6K ﹤0.01%
5,400
+4,600
+575% +$1.37M
PLG
4597
Platinum Group Metals
PLG
$164M
$34.2K ﹤0.01%
19,325
+2,145
+12% +$5.19K
AMZN icon
4598
CALL
Amazon
AMZN
$2.92T
$33.6K ﹤0.01%
1,200
+200
+20% +$44K
BLDP
4599
Ballard Power Systems
BLDP
$805M
$32.7K ﹤0.01%
+13,509
New +$32.2K
AMZN icon
4600
PUT
Amazon
AMZN
$2.92T
$32.5K ﹤0.01%
1,100
+800
+267% +$176K

Similar funds

Cetera Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Cetera Investment Advisers held 5,012 positions worth $94B, up 2.7% from $91.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Cetera Investment Advisers deployed $4.21B of net new capital in Q1 2026, opening 327 new positions and adding to 2,706 existing holdings. Its largest new stake was iShares Defense Industrials Active ETF: 2,806,909 shares worth $91.8M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Schwab US Dividend Equity ETF, an estimated $316M trimmed.

  • Cetera Investment Advisers's largest Q1 2026 buy was iShares Defense Industrials Active ETF: 2,806,909 shares worth $91.8M.
  • Cetera Investment Advisers added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $146M increase.
  • Cetera Investment Advisers's biggest Q1 2026 reduction was Schwab US Dividend Equity ETF, cutting an estimated $316M.
  • Cetera Investment Advisers fully exited PotlatchDeltic in Q1 2026, selling an estimated $7.94M.
  • Cetera Investment Advisers's ten largest holdings make up 16% of its $94B portfolio in Q1 2026.
  • Cetera Investment Advisers opened 327 new positions and closed 222 in Q1 2026.
  • Cetera Investment Advisers's portfolio value rose 2.7% quarter-over-quarter to $94B.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.